Fructose 1,6-bisphosphate quantification in HepG2 liver cancer cell line.
ST003191 · Metabolomics Workbench
TL;DR — A 9.6 KB metabolomics / lipidomics deposit (ST003191, 3 file(s), liver) in the MASLD / NAFLD / NASH data lake. under-mined portal (Metabolomics Workbench); modality=metabolomics.
0. Summary
Biological premise.
The following premise is sourced from the repository record (not fabricated).
Quantification of specific fructose 1,6-bisphosphate (FBP) concentrations in HepG2 cells. A minimum of 1 million cells per replicate and condition will be grown and treated. Glucose-starved cells will be either treated with 10 mM glucose, 2.5 μM Oligomycin, 50 mM 2-deoxy-D-glucose (2-DG), or not treated. Cells will be lysed and processed for FBP quantification using an isotope FBP standard by LC/MS.
Quantification of specific fructose 1,6-bisphosphate (FBP) concentrations in HepG2 cells. A minimum of 1 million cells per replicate and condition will be grown and treated. Glucose-starved cells will be either treated with 10 mM glucose, 2.5 μM Oligomycin, 50 mM 2-deoxy-D-glucose (2-DG), or not treated. Cells will be lysed and processed for FBP quantification using an isotope FBP standard by LC/MS.
Every file in this dataset is a metabolomics / lipidomics readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from Metabolomics Workbench.
Assay and processing.
Modality: metabolomics / lipidomics (repository subtype: metabolomics). Tier-1 (must-have) for this modality = feature × sample intensity matrix (MAF/data table) + sample factors; Tier-2 (recommended) = feature annotation (m/z, RT, HMDB/KEGG ids), author DE/pathway tables, QC pools; Tier-3 (optional / raw) = raw spectra (.mzML/.cdf/vendor), peak-picking parameters. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.
Sources.
- ST003191 — Metabolomics Workbench deposit (under-mined portal (Metabolomics Workbench); modality=metabolomics).
- PMIDs: none recorded in the index for this deposit.
| Disease | MASLD / NAFLD / NASH |
| Assay / modality | metabolomics / lipidomics — metabolomics |
| Organisms | unspecified |
| Repository | Metabolomics Workbench — NIH Metabolomics Workbench |
| Accession | ST003191 |
| Access | Public (open); files mirrored in this dataset's input/ folder. |
| Number of studies | 1 |
| Number of files | 3 |
| Total size | 9,584 bytes (≈ 9.6 KB) |
1. Datasets — sample sources, protocols, experiment design and metadata
Landed sources at a glance.
| Source | Access | Files |
|---|---|---|
| Metabolomics Workbench | public / OPEN-processed | 3 |
The deposit at a glance.
| Accession | Description | Organism | Samples | Scale |
|---|---|---|---|---|
| ST003191 | under-mined portal (Metabolomics Workbench); modality=metabolomics | unspecified | n/a | 3 files · 9.6 KB |
ST003191 — Fructose 1,6-bisphosphate quantification in HepG2 liver cancer cell line.
Metabolomics Workbench record · 3 files · 9.6 KB
-
Sample source. unspecified material; MASLD/NAFLD/NASH context (under-mined portal (Metabolomics Workbench); modality=metabolomics).
-
Samples and retention. Sample count not declared in the repository index; see the per-sample metadata file(s) listed below.
-
Experiment design. Repository subtype: metabolomics; disease context MASLD/NAFLD/NASH.
-
Metadata available. See the annotated file table below; per-sample metadata ships in the ISA-Tab / SDRF / metadata file(s) where present.
-
Files (annotated).
File What it is ST003191_mwtab.txtMetabolomics Workbench mwTab — study design, sample factors, and named-metabolite × sample data table (105 data rows × 1 cols) ST003191_data.txtNamed-metabolite × sample data table (feature intensities) (19 data rows × 2 cols) ST003191_named_metabolites.txtNamed-metabolite reference list (identified features) (9 data rows × 2 cols) -
How this experiment became a dataset. ST003191 resolved via the Metabolomics Workbench record API → 3 open file(s) fetched into this dataset's
input/folder → sizes verified on disk (9,584 bytes (≈ 9.6 KB)). -
Completeness (metabolomics / lipidomics). Present: feature/intensity table (Tier-1); metabolite annotation (Tier-2). Not detected among landed files: sample factors (Tier-1). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)
2. Analyses this atlas supports
- Differential-abundance / pathway analysis. Start from
ST003191_data.txt(feature × sample intensities) to run group contrasts and metabolite-set enrichment. - Cross-cohort MASLD integration. Combine this deposit (ST003191) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.
Reproduce. All files are in this dataset's input/ folder; the source of record is ST003191 (https://www.metabolomicsworkbench.org/rest/study/study_id/ST003191/mwtab/txt). Re-fetch with the MASLD crawler (masld_download_pass.py --only ST003191); sizes are verified on disk and recorded in this dataset's metadata.json.
Citation
Fructose 1,6-bisphosphate quantification in HepG2 liver cancer cell line.. Metabolomics Workbench accession ST003191. https://www.metabolomicsworkbench.org/rest/study/study_id/ST003191/mwtab/txt
About this dataset
This 10x Genomics dataset provides single-cell gene expression from liver samples, with disease state recorded as MASLD/NAFLD/NASH.
Analyze it in Drylab
Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:
- Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
- Normalize, select variable genes, then cluster the cells and draw a UMAP.
- Annotate clusters with marker genes and compare the cell-type mix between conditions.
- Run differential expression between cell types or samples to characterize masld/nafld/nash biology.